Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $3.49
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Mar 25, 21 | Maxim Group | upgrade | Hold | Buy |
| Nov 25, 20 | Maxim Group | downgrade | Buy | Hold |
| Nov 25, 20 | Maxim Group | maintain | Buy | Buy |
| Oct 3, 19 | Maxim Group | downgrade | Buy | Hold |
| Aug 15, 18 | Maxim Group | maintain | Buy | Buy |
| Jul 13, 17 | Maxim Group | maintain | Buy | Buy |
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Jun 30, 26 | Sullivan James David | officer, other: Chief Legal Officer | A-Award | 250 @ $3.83 | $958 |
Daily · Wilder smoothing
| Jun 30, 26 |
| Depasquale Michael W |
| director, officer, other: Chief Executive Officer |
| A-Award |
| 250 @ $3.83 |
| $958 |
| Jun 30, 26 | Lacous Mira K | officer: Chief Technology Officer | A-Award | 250 @ $3.83 | $958 |
| Dec 31, 25 | Lacous Mira K | officer: Chief Technology Officer | A-Award | 2,500 @ $0.46 | $1.15K |
| Dec 31, 25 | Sullivan James David | officer, other: Chief Legal Officer | A-Award | 2,500 @ $0.46 | $1.15K |
| Dec 31, 25 | Depasquale Michael W | director, officer, other: Chief Executive Officer | A-Award | 2,500 @ $0.46 | $1.15K |
| Sep 16, 25 | Depasquale Michael W | director, officer, other: Chief Executive Officer | P-Purchase | 1,617 @ $0.84 | $1.36K |
| Sep 15, 25 | Depasquale Michael W | director, officer, other: Chief Executive Officer | P-Purchase | 2,500 @ $0.75 | $1.88K |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 63.38 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 44.97 | Oscillator | Neutral |
| Williams %R (14) | -28.36 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.05 (Hist 0.13) | Oscillator | Strong Buy |
| Average Directional Index (14) | 34.84 (+DI 43.7 / -DI 14.8) | Trend | Strong Buy |
| EMA 20 | 2.49 | MA | Strong Buy |
| SMA 20 | 2.34 | MA | Strong Buy |
| EMA 50 | 2.76 | MA | Strong Buy |
| SMA 50 | 2.60 | MA | Strong Buy |
| SMA 200 | 4.64 | MA | Strong Sell |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
BIO-key (BKYI) secured another Middle East government contract (new customer) for its passwordless, biometric, identity & access management (IAM) solutions
HOLMDEL, N.J., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and tokenless Identity-Bound Biometric™ (IBB) authentication, today announced the appointment of Stephen Morrow as President of PortalGuard®, the Company's flagship IAM platform.
BIO-key (BKYI) Adds New Middle East Government Security Agency, Expands Regional Footprint, Supports National Digital Transformation & Cybersecurity goals.
BIO-key (BKYI) Partners with Al Majlis Group, Founded by His Excellency Dherar Belhoul Al Falasi, to Expand Identity Security Across Arabian Gulf Region.
HOLMDEL, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and tokenless Identity-Bound Biometrics™ (IBB) authentication, today announced that its Passkey:YOU™ authenticator has received Full Certification from the FIDO Alliance, the industry body behind the FIDO2/WebAuthn/Passkey standard now in widespread use to allow phish-resistant sign in without typing a password.
HOLMDEL, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, announced that its CEO Michael DePasquale will be available for virtual meetings at H.C.
BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript
BIO-key's (BKYI)Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -0.82 | -0.56 | Beat 31.7% | $1.92M |
| May 18, 2026 | -0.60 | -0.15 | Beat 75.0% | $2.15M |
| Mar 31, 2026 | -0.70 | -1.90 | Miss -171.4% | $1.24M |
| Nov 14, 2025 | -1.20 | -1.50 | Miss -25.0% | $1.55M |
| Aug 13, 2025 | -1.50 | -2.00 | Miss -33.3% | $1.70M |
| May 15, 2025 | -2.40 | -1.60 | Beat 33.3% | $1.61M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| S-1 | Oct 9, 2026 | 2026-10-09 17:00:43 | View |
| DEFA14A | Oct 6, 2026 | 2026-10-06 16:48:35 | View |
| 8-K | Oct 6, 2026 | 2026-10-06 16:48:20 | View |
| 8-K | Oct 2, 2026 | 2026-10-02 17:02:23 | View |
| DEFA14A | Sep 8, 2026 | 2026-09-08 17:04:20 | View |
| 8-K | Sep 8, 2026 | 2026-09-08 17:04:03 | View |
| DEFA14A | Aug 24, 2026 | 2026-08-24 10:09:19 | View |
| PRE 14A | Aug 14, 2026 | 2026-08-14 17:24:13 | View |
| 8-K | Aug 14, 2026 | 2026-08-14 08:01:16 | View |
| 8-K | Aug 13, 2026 | 2026-08-13 16:56:20 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | BKYI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.9x | -1.1x · sector 44.2x | Discount |
| Forward P/E (FY26E) | -2.2x | EPS est. -1.62 | Elevated |
| Price / Book | 0.8x | 1.0x | Discount |
| Price / Sales | 0.7x | 1.1x | Discount |
| EV / EBITDA | -1.3x | -0.9x | Elevated |
| Return on equity | -53.8% | — | Weak |
| Gross margin | 81.7% | 62.0% | Above hist. |
| Debt / Equity | 0.03 | 0.31 | Conservative |
| Piotroski / Altman Z | 2/9 | Z -25.29 | Distress |
Discounted cash flow model